FATE THERAPEUTICS INC — Director's Dealing 2018

May 16, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FATE THERAPEUTICS INC (FATE)
CIK: 0001434316
Period of Report: 2018-05-15

Reporting Person: ABBOT STEWART (Chief Development Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-05-15	Common Stock	M	2916	$4.89	Acquired	46779	Direct
2018-05-15	Common Stock	M	18138	$6.90	Acquired	64917	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-05-15	Stock Option (right to buy)	$4.89	M	2916	Disposed	2025-10-15	Common Stock (2916)	Direct
2018-05-15	Stock Option (right to buy)	$6.90	M	18138	Disposed	2025-08-03	Common Stock (18138)	Direct

Footnotes

F1: The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning on November 12, 2015, such that this option is fully exercisable on October 12, 2019, subject to the recipient's continued service relationship with the Issuer. This option is subject to an accelerated vesting upon a change of control of the Issuer and in the event of termination of employment under certain circumstances following a change of control of the Issuer.

F2: Not applicable.

F3: The shares subject to the option shall vest and become exercisable at the rate of 1/4th of the shares on July 13, 2016 and 1/48th of the shares each month thereafter such that this option is fully exercisable on July 13, 2019. This option is subject to an accelerated vesting upon a change of control of the Issuer and in the event of termination of employment under certain circumstances following a change of control of the Issuer.